April 20, 2024


Eli Lilly building

Image: Mike Blake (Reuters)

Novo Nordisk rival Eli Lilly, known for its Zepbound and Mounjaro medications, is also developing a new weight loss drug. Early trials of the company’s oral drug, Orforglipron, found that it helped users lose an average of nearly 15% of weight after 36 weeks.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *